Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics Congress with Record 20 Research Presentations
Yatsen Group Expands Scientific Presence at Prestigious IFSCC Cosmetics Congress with Record 20 Research Presentations
PR Newswire
GUANGZHOU, China, Oct. 15, 2026
GUANGZHOU, China, Oct. 15, 2026 /PRNewswire/ -- Yatsen Holding Limited (NYSE: YSG) (Yatsen Group), a leading China-based beauty group, presented a record 20 research submissions at the 36th IFSCC Congress in Perth — nearly double its 2025 total and marking its fifth consecutive year at the world's leading conference for cosmetics science. Yatsen's 20 studies were selected from more than 1,200 submissions following three rounds of expert review, underscoring its sustained investment in scientific innovation and its leading role in China's cosmetics sector.
Breakthroughs Across Nine Cutting-Edge Fields
"IFSCC is a leading science forum in cosmetic industry" said Jing Cheng, Chief Scientific Officer of Yatsen Group. "Achieving a record 20 accepted contributions across our core brands reflects the collaborative strength of our global R&D ecosystem. We remain committed to translating cutting-edge science into high-efficacy beauty solutions for consumers worldwide."
Yatsen's featured research spanned nine cutting-edge fields, including advanced scientific mechanisms, active ingredient innovation, efficacy evaluation, skin microbiome, color cosmetics innovation, skin neuroscience, preservative and microbiological science, computational toxicology, and formulation & delivery system innovation.
At the congress, Yatsen Group's R&D Director, Yi Deng, delivered a podium presentation on a novel microbiology testing methodology that minimizes preservative interference and reduces false negatives, establishing a quality assurance standard more reflective of real-world production across cosmetic formats.
Additionally, Yatsen's major brands — DR.WU, Galénic, Eve Lom and Perfect Diary, — presented technological applications spanning gentle skincare, anti-aging, eye-area care, clinical skin research and color cosmetics innovation.
Sustained R&D Commitment
Yatsen's R&D network spans an advanced manufacturing hub, three global R&D centers, six joint laboratories and more than 20 joint research platforms. The Group has invested over RMB 770 million in R&D, with annual spending exceeding 3% of revenue for four consecutive years. As of June 30, 2026, it filed 282 patent applications and published 55 academic papers.
About Yatsen Group
Yatsen Holding Limited (NYSE: YSG) (Yatsen Group) is a leading China-based beauty group with the vision of becoming a world-class beauty innovation pioneer. Founded in 2016, its brands — including Galénic, DR.WU (mainland China business), Eve Lom, Perfect Diary and Little Ondine — cover consumer segments from the mass market to prestige and clinical-grade skincare.
Media Contact:
Website: www.yatsenglobal.com
LinkedIn: www.linkedin.com/company/yatsen
Contact:public.affairs@yatsenglobal.com
SOURCE Yatsen Holding Limited
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
6 ETFs To Diversify Away From AI
Why This Vanguard ETF Is One of the Best
The Best AI Stocks to Buy Now
United States